Long-term outcomes after third liver transplant

C. Burcin Taner, Deniz Balci, Darrin L. Willingham, Andrew P. Keaveny, Barry G. Rosser, Juan M. Canabal, Timothy S J Shine, Denise Harnois, David J. Kramer, Justin H Nguyen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: Orthotopic liver transplant is the treatment of choice for patients with end-stage liver disease. Patients with first graft failure requiring liver retransplant are commonly seen at most liver transplant centers. However, patients with a second graft failure requiring a third graft are uncommon. Liver retransplant in this setting has only been pursued at a few large transplant centers. Materials and Methods: This is a retrospective analysis of the long-term outcomes of recipients who underwent 3 or more orthotopic liver transplants. Between February 1998 and August 2009, 24 patients had 3 or more orthotopic liver transplants at the Mayo Clinic in Florida. Results: Mean patient survival was 103.8 months for the study cohort. Actuarial patient survival after the last orthotopic liver transplant in -1, -5, and -10 years was 60%, 40%, 33%. Patients were transplanted with lower donor risk index score grafts in each subsequent orthotopic liver transplant. Patients who had a graft with a donor risk index score > 1.6 at the time of the third orthotopic liver transplant had significantly lower survival rate compared with those with grafts with a donor risk index score ≤ 1.6. Conclusions: Multiple liver retransplants offer acceptable patient survival. Each transplant program must decide whether to do multiple orthotopic liver transplants based on the program's transplant volume and outcomes to help this subgroup of patients. The concerns of potentially decreasing access to first time orthotopic liver transplant candidates should also be weighed in the decision to move forward.

Original languageEnglish (US)
Pages (from-to)98-104
Number of pages7
JournalExperimental and Clinical Transplantation
Volume9
Issue number2
StatePublished - Apr 2011

Fingerprint

Transplants
Liver
Tissue Donors
Survival
End Stage Liver Disease
Liver Failure
Cohort Studies
Survival Rate

Keywords

  • Donor selection
  • Liver retransplantation
  • Survival

ASJC Scopus subject areas

  • Transplantation

Cite this

Taner, C. B., Balci, D., Willingham, D. L., Keaveny, A. P., Rosser, B. G., Canabal, J. M., ... Nguyen, J. H. (2011). Long-term outcomes after third liver transplant. Experimental and Clinical Transplantation, 9(2), 98-104.

Long-term outcomes after third liver transplant. / Taner, C. Burcin; Balci, Deniz; Willingham, Darrin L.; Keaveny, Andrew P.; Rosser, Barry G.; Canabal, Juan M.; Shine, Timothy S J; Harnois, Denise; Kramer, David J.; Nguyen, Justin H.

In: Experimental and Clinical Transplantation, Vol. 9, No. 2, 04.2011, p. 98-104.

Research output: Contribution to journalArticle

Taner, CB, Balci, D, Willingham, DL, Keaveny, AP, Rosser, BG, Canabal, JM, Shine, TSJ, Harnois, D, Kramer, DJ & Nguyen, JH 2011, 'Long-term outcomes after third liver transplant', Experimental and Clinical Transplantation, vol. 9, no. 2, pp. 98-104.
Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM et al. Long-term outcomes after third liver transplant. Experimental and Clinical Transplantation. 2011 Apr;9(2):98-104.
Taner, C. Burcin ; Balci, Deniz ; Willingham, Darrin L. ; Keaveny, Andrew P. ; Rosser, Barry G. ; Canabal, Juan M. ; Shine, Timothy S J ; Harnois, Denise ; Kramer, David J. ; Nguyen, Justin H. / Long-term outcomes after third liver transplant. In: Experimental and Clinical Transplantation. 2011 ; Vol. 9, No. 2. pp. 98-104.
@article{7fc50e959cfc4fb9ab4a9d8587e2dc3d,
title = "Long-term outcomes after third liver transplant",
abstract = "Objectives: Orthotopic liver transplant is the treatment of choice for patients with end-stage liver disease. Patients with first graft failure requiring liver retransplant are commonly seen at most liver transplant centers. However, patients with a second graft failure requiring a third graft are uncommon. Liver retransplant in this setting has only been pursued at a few large transplant centers. Materials and Methods: This is a retrospective analysis of the long-term outcomes of recipients who underwent 3 or more orthotopic liver transplants. Between February 1998 and August 2009, 24 patients had 3 or more orthotopic liver transplants at the Mayo Clinic in Florida. Results: Mean patient survival was 103.8 months for the study cohort. Actuarial patient survival after the last orthotopic liver transplant in -1, -5, and -10 years was 60{\%}, 40{\%}, 33{\%}. Patients were transplanted with lower donor risk index score grafts in each subsequent orthotopic liver transplant. Patients who had a graft with a donor risk index score > 1.6 at the time of the third orthotopic liver transplant had significantly lower survival rate compared with those with grafts with a donor risk index score ≤ 1.6. Conclusions: Multiple liver retransplants offer acceptable patient survival. Each transplant program must decide whether to do multiple orthotopic liver transplants based on the program's transplant volume and outcomes to help this subgroup of patients. The concerns of potentially decreasing access to first time orthotopic liver transplant candidates should also be weighed in the decision to move forward.",
keywords = "Donor selection, Liver retransplantation, Survival",
author = "Taner, {C. Burcin} and Deniz Balci and Willingham, {Darrin L.} and Keaveny, {Andrew P.} and Rosser, {Barry G.} and Canabal, {Juan M.} and Shine, {Timothy S J} and Denise Harnois and Kramer, {David J.} and Nguyen, {Justin H}",
year = "2011",
month = "4",
language = "English (US)",
volume = "9",
pages = "98--104",
journal = "Experimental and Clinical Transplantation",
issn = "1304-0855",
publisher = "Baskent University",
number = "2",

}

TY - JOUR

T1 - Long-term outcomes after third liver transplant

AU - Taner, C. Burcin

AU - Balci, Deniz

AU - Willingham, Darrin L.

AU - Keaveny, Andrew P.

AU - Rosser, Barry G.

AU - Canabal, Juan M.

AU - Shine, Timothy S J

AU - Harnois, Denise

AU - Kramer, David J.

AU - Nguyen, Justin H

PY - 2011/4

Y1 - 2011/4

N2 - Objectives: Orthotopic liver transplant is the treatment of choice for patients with end-stage liver disease. Patients with first graft failure requiring liver retransplant are commonly seen at most liver transplant centers. However, patients with a second graft failure requiring a third graft are uncommon. Liver retransplant in this setting has only been pursued at a few large transplant centers. Materials and Methods: This is a retrospective analysis of the long-term outcomes of recipients who underwent 3 or more orthotopic liver transplants. Between February 1998 and August 2009, 24 patients had 3 or more orthotopic liver transplants at the Mayo Clinic in Florida. Results: Mean patient survival was 103.8 months for the study cohort. Actuarial patient survival after the last orthotopic liver transplant in -1, -5, and -10 years was 60%, 40%, 33%. Patients were transplanted with lower donor risk index score grafts in each subsequent orthotopic liver transplant. Patients who had a graft with a donor risk index score > 1.6 at the time of the third orthotopic liver transplant had significantly lower survival rate compared with those with grafts with a donor risk index score ≤ 1.6. Conclusions: Multiple liver retransplants offer acceptable patient survival. Each transplant program must decide whether to do multiple orthotopic liver transplants based on the program's transplant volume and outcomes to help this subgroup of patients. The concerns of potentially decreasing access to first time orthotopic liver transplant candidates should also be weighed in the decision to move forward.

AB - Objectives: Orthotopic liver transplant is the treatment of choice for patients with end-stage liver disease. Patients with first graft failure requiring liver retransplant are commonly seen at most liver transplant centers. However, patients with a second graft failure requiring a third graft are uncommon. Liver retransplant in this setting has only been pursued at a few large transplant centers. Materials and Methods: This is a retrospective analysis of the long-term outcomes of recipients who underwent 3 or more orthotopic liver transplants. Between February 1998 and August 2009, 24 patients had 3 or more orthotopic liver transplants at the Mayo Clinic in Florida. Results: Mean patient survival was 103.8 months for the study cohort. Actuarial patient survival after the last orthotopic liver transplant in -1, -5, and -10 years was 60%, 40%, 33%. Patients were transplanted with lower donor risk index score grafts in each subsequent orthotopic liver transplant. Patients who had a graft with a donor risk index score > 1.6 at the time of the third orthotopic liver transplant had significantly lower survival rate compared with those with grafts with a donor risk index score ≤ 1.6. Conclusions: Multiple liver retransplants offer acceptable patient survival. Each transplant program must decide whether to do multiple orthotopic liver transplants based on the program's transplant volume and outcomes to help this subgroup of patients. The concerns of potentially decreasing access to first time orthotopic liver transplant candidates should also be weighed in the decision to move forward.

KW - Donor selection

KW - Liver retransplantation

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=79955932553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955932553&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 98

EP - 104

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1304-0855

IS - 2

ER -